Jun 26, 2026 07:00AM
Jun 8, 2026 07:31AM
Jun 8, 2026 07:30AM
May 26, 2026 07:30AM
May 8, 2026 07:30AM
Apr 28, 2026 07:30AM
Apr 28, 2026 07:30AM Soligenix halts phase 3 trial of HyBryte for lymphoma treatment
Apr 28, 2026 07:30AM
Apr 2, 2026 07:30AM
Apr 2, 2026 07:30AM
Mar 31, 2026 07:32AM
Mar 31, 2026 07:30AM
Mar 26, 2026 07:31AM
Mar 26, 2026 07:30AM Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
Mar 23, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 10, 2026 07:30AM
Mar 10, 2026 07:30AM
Feb 26, 2026 07:32AM
Feb 26, 2026 07:30AM
Feb 24, 2026 07:30AM Soligenix to Present at BIO Investment & Growth Summit
Feb 12, 2026 07:31AM
Feb 12, 2026 07:30AM
Dec 18, 2025 07:30AM
Dec 18, 2025 07:30AM
Dec 17, 2025 07:30AM
Dec 17, 2025 07:30AM
Dec 10, 2025 08:30AM NetworkNewsAudio Announces Audio Press Release (APR) on Final Confirmatory Clinical Study Being Done for Treatment of Rare Disease
Dec 5, 2025 08:30AM
Dec 5, 2025 08:30AM
Dec 4, 2025 08:30AM
Dec 3, 2025 08:30AM
Dec 2, 2025 08:30AM
Nov 19, 2025 07:30AM
Nov 19, 2025 07:30AM Soligenix Achieves Enrollment Milestone for Planned Interim Analysis in Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
Nov 7, 2025 07:30AM
Oct 14, 2025 07:30AM
Oct 14, 2025 07:30AM
Oct 8, 2025 07:00AM
Oct 7, 2025 07:30AM
Oct 7, 2025 07:30AM
Sep 30, 2025 07:30AM Soligenix expands European medical board for lymphoma drug approval push
Sep 30, 2025 07:30AM
Sep 29, 2025 04:05PM
Sep 29, 2025 04:05PM
Sep 26, 2025 06:34AM
Sep 26, 2025 06:33AM
Sep 23, 2025 07:30AM
Sep 23, 2025 07:30AM Soligenix Announces Appointment of Former White House Economic Adviser Tomas J. Philipson, PhD as Strategic Advisor
Sep 4, 2025 07:31AM

325,893 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All